APIXABAN-FORMULIERUNGEN

European patent · EP3251660 · Deleted

Register entry

Publication number
EP3251660
Application number
EP17175788
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 24, 2011
Published
Dec 6, 2017
Granted
Oct 16, 2019
Deleted
Apr 24, 2024
Reason
Revoked in opposition
IPC classes
A61K 9/20 (2006.01)
A61K 31/4545 (2006.01)
A61P 7/02 (2006.01)
Priority
US 308056 P 25.02.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 26, 2024

    Publication

    Published in Swissreg on 26.04.2024

  2. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  3. Mar 27, 2024

    Change

    Published in Swissreg on 27.03.2024

  4. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  5. Dec 27, 2023

    Change

    Published in Swissreg on 27.12.2023

  6. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  7. Jan 9, 2023

    Address changed

    Representative
    ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg

    Published in Swissreg on 09.01.2023

  8. Apr 20, 2022

    Change

    Published in Swissreg on 20.04.2022

10 earlier entries
  1. Feb 16, 2022

    Change

    Published in Swissreg on 16.02.2022

  2. Oct 27, 2021

    Change

    Published in Swissreg on 27.10.2021

  3. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  4. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  5. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  6. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  7. Sep 22, 2021

    Change

    Published in Swissreg on 22.09.2021

  8. Jun 4, 2020

    Address changed

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich

    Published in Swissreg on 04.06.2020

  9. Nov 5, 2019

    Agent entered

    Representative
    Servopatent GmbH, Resirain 1, 8125 Zollikerberg

    Published in Swissreg on 05.11.2019

  10. Oct 16, 2019

    Granted

    Published in Swissreg on 16.10.2019

Parties

Holder

Pfizer Inc.

235 East 42nd Street, New York, NY 10017, US

Bristol-Myers Squibb Holdings Ireland Unlimited Company

Hinterbergstrasse 16, 6312 Steinhausen

Agent

Servopatent GmbH

Bühlstrasse 1, 8125 Zollikerberg

Inventor

FROST, Charles

Princton, NJ New Jersey 08543, US

PATEL, Jatin

Princton, NJ New Jersey 08543, US

JIA, Jingpin

Princton, NJ New Jersey 08543, US

VEMA-VARAPU, Chandra

Princton, NJ New Jersey 08543, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.